Natasha Sheybani
(Redirected from Draft:Natasha Sheybani)
 | The topic of this article may not meet Wikipedia's notability guideline for biographies. (January 2023) |
Natasha Sheybani | |
|---|---|
| Alma mater | Virginia Commonwealth University (BS)
University of Virginia (Ph.D) Stanford University (Post-Doc) |
| Known for | Focused Ultrasound Research |
| Scientific career | |
| Fields | Biomedical Engineering
Oncology Radiology |
Natasha Sheybani is an American biomedical engineer who is an assistant professor of Biomedical engineering at the University of Virginia.[1][2]
She was named one of Forbes 30 Under 30 in Science in 2022 and a STAT Wunderkind in 2020.[3][4][5]
Education
[edit]Sheybani earned her Bachelor of Science in Biomedical Engineering from Virginia Commonwealth University in 2015.[1] She went on to earn a Ph.D in Biomedical Engineering at the University of Virginia in 2020.[6][2]
Publications
[edit]- Curley, Colleen T.; Sheybani, Natasha D.; Bullock, Timothy N.; Price, Richard J. (2017-08-23). "Focused Ultrasound Immunotherapy for Central Nervous System Pathologies: Challenges and Opportunities". Theranostics. 7 (15): 3608–3623. doi:10.7150/thno.21225. ISSN 1838-7640. PMC 5667336. PMID 29109764.[7]
- Sheybani, N.D., A.R. Witter, W.J. Garrison, G.W. Miller, R.J. Price, T.N.J. Bullock (2021) Profiling of the Immune Landscape in Murine Glioblastoma following Blood Brain/Tumor Barrier Disruption with MR Image-guided Focused Ultrasound. J Neurooncol. DOI: 10.1007/s11060-021-03887-4. PMID 34734364.[8]
- Clark, R.A., Z.G. Garman, R.J. Price, and N.D. Sheybani (2021) Functional Intersections Between Extracellular Vesicles and Oncolytic Therapies. Trends Pharmacol Sci. DOI: 10.1016/j.tips.2021.09.001. PMID 34598797.[9]
- Sheybani, N.D., V.R. Breza, S. Paul, K.S. McCauley, S.S. Berr, G.W. Miller, K.D. Neumann, and R.J. Price (2021) ImmunoPET-Informed Sequence for Focused Ultrasound-Targeted mCD47 Blockade Controls Glioma. J Control Release. DOI:10.1016/j.jconrel.2021.01.023. PMID 33476735.[10]
- Sheybani, N.D., A.J. Batts, A.S. Mathew, E.A. Thim, and R.J. Price (2020) Focused Ultrasound Hyperthermia Augments Release of Glioma-Derived Extracellular Vesicles with Differential Immunomodulatory Capacity. Theranostics. 10:7436-7447. PMID 32642004.[11]
References
[edit]- ^ a b Sheybani, Natasha Diba; Charlottesville, Ph D. Biomedical Engineering MR5 1123 MR5 1225 415 Lane Road | Box 800759 (2022-02-14). "Natasha D. Sheybani". University of Virginia School of Engineering and Applied Science. Retrieved 2022-11-15.
{{cite web}}: CS1 maint: numeric names: authors list (link) - ^ a b "Former UVA student honored as upcoming scientific superstar". www.cbs19news.com. Retrieved 2022-11-15.
- ^ Paschall, C. J. (17 November 2020). "Researcher named 2020 "Wunderkind" for research done at UVA". www.nbc29.com. Retrieved 2022-11-15.
- ^ "Engineering professor's work with targeted ultrasound waves honored in Forbes "30 Under 30"". The Cavalier Daily - University of Virginia's Student Newspaper. Retrieved 2022-11-15.
- ^ "Meet the Trio of UVA Alumni on the 2022 Forbes '30 Under 30' Lists". UVA Today. 2021-12-23. Retrieved 2022-11-15.
- ^ "Natasha Sheybani". STAT. Retrieved 2022-05-02.
- ^ Curley, Colleen T.; Sheybani, Natasha D.; Bullock, Timothy N.; Price, Richard J. (2017). "Focused Ultrasound Immunotherapy for Central Nervous System Pathologies: Challenges and Opportunities". Theranostics. 7 (15): 3608–3623. doi:10.7150/thno.21225. ISSN 1838-7640. PMC 5667336. PMID 29109764.
- ^ Sheybani, Natasha D.; Witter, Alexandra R.; Garrison, William J.; Miller, G. Wilson; Price, Richard J.; Bullock, Timothy N. J. (January 2022). "Profiling of the immune landscape in murine glioblastoma following blood brain/tumor barrier disruption with MR image-guided focused ultrasound". Journal of Neuro-Oncology. 156 (1): 109–122. doi:10.1007/s11060-021-03887-4. ISSN 1573-7373. PMC 8714701. PMID 34734364.
- ^ Clark, Ryan A.; Garman, Zoe G.; Price, Richard J.; Sheybani, Natasha D. (November 2021). "Functional intersections between extracellular vesicles and oncolytic therapies". Trends in Pharmacological Sciences. 42 (11): 883–896. doi:10.1016/j.tips.2021.09.001. ISSN 1873-3735. PMC 8526420. PMID 34598797.
- ^ Sheybani, Natasha D.; Breza, Victoria R.; Paul, Soumen; McCauley, Katelyenn S.; Berr, Stuart S.; Miller, G. Wilson; Neumann, Kiel D.; Price, Richard J. (2021-03-10). "ImmunoPET-informed sequence for focused ultrasound-targeted mCD47 blockade controls glioma". Journal of Controlled Release. 331: 19–29. doi:10.1016/j.jconrel.2021.01.023. ISSN 0168-3659. PMC 7946780. PMID 33476735.
- ^ Sheybani, Natasha D.; Batts, Alec J.; Mathew, Alexander S.; Thim, E. Andrew; Price, Richard J. (2020-06-12). "Focused Ultrasound Hyperthermia Augments Release of Glioma-derived Extracellular Vesicles with Differential Immunomodulatory Capacity". Theranostics. 10 (16): 7436–7447. doi:10.7150/thno.46534. ISSN 1838-7640. PMC 7330848. PMID 32642004.
External links
[edit]- Natasha Sheybani publications indexed by Google Scholar